Clinical trial
An Open-label Observation Study of Topiramate Administration as Adjuvant Therapy for Focal Epilepsy, Lennox-Gastaut Syndrome Epileptic Seizures and Generalized Tonoclonic Seizures in Adults and Children Aged 2 Years and Older
NCT00297349 is registered in ClinicalTrials.gov with Janssen Cilag Pharmaceutica S.A.C.I., Greece as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Observation Study of Topiramate Administration as Adjuvant Therapy for Focal Epilepsy, Lennox-Gastaut Syndrome Epileptic Seizures and Generalized Tonoclonic Seizures in Adults and Children Aged 2 Years and Older
- Lead sponsor
- Janssen Cilag Pharmaceutica S.A.C.I., Greece
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2003
- Completion date
- June 30, 2005
- Enrollment
- 153 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.